Dr. Ernesto N. Levy, MD

Dr. Levy practices at Rheumatic Diseases Clinic of Oklahoma in Oklahoma City, Oklahoma.

Dr. Levy's NPI, 1760431225, was assigned on May 10, 2006. Dr. Levy holds Oklahoma license 40813.

Dr. Levy's primary practice is Rheumatic Diseases Clinic of Oklahoma, at 1015 N Shartel Ave, Oklahoma City, OK 73102 in Oklahoma County. The practice phone is (405) 606-8070.

Dr. Levy's primary practice is Rheumatic Diseases Clinic of Oklahoma in Oklahoma City, Oklahoma. Dr. Levy is also affiliated with Terrebonne General Health System. The medical group on file is South Louisiana Medical Associates. Dmand AI also links Dr. Levy to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levy practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Levy's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Levy's licenses on file in 9 states: Oklahoma, Arizona, Indiana, Louisiana, Maine, Missouri, New York, Pennsylvania and South Carolina.

CMS data shows 474 Medicare services from Dr. Levy across 7 procedure codes in 2024, for 69 Medicare patients. Medicare paid $9,822 for them. Every service was in an office.

CMS counts 69 Medicare patients who saw Dr. Levy in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have arthritis, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levy's median patient age at 62, with 72% women.

In 2024, Dr. Levy wrote 406 Medicare Part D claims for 85 patients. 78% of them were for generic drugs. CMS names the drug for 286 of them, across 6 drugs with 11 or more claims each, at $132,008 in total drug cost. In 2023, CMS named 64 claims across 3 drugs.

Dr. Levy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 339 general payments to Dr. Levy from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Amgen Inc. paid the most, $1,036.